Terms: = Lung cancer AND SOCS1, O15524, 8651, ENSG00000185338, SOCS-1, SSI-1, SSI1, Cish1, JAB, CISH1, CIS1, TIP3
44 results:
1. LncRNA-HOXC-AS2 regulates tumor-associated macrophage polarization through the STAT1/socs1 and STAT1/CIITA pathways to promote the progression of non-small cell lung cancer.
Yin C; Li J; Li S; Yang X; Lu Y; Wang C; Liu B
Cell Signal; 2024 Mar; 115():111031. PubMed ID: 38168631
[TBL] [Abstract] [Full Text] [Related]
2. Gene expression analysis of SOCS, STAT and PIAS genes in lung cancer patients.
Abolghasemi S; Bikhof Torbati M; Pakzad P; Ghafouri-Fard S
Pathol Res Pract; 2023 Sep; 249():154760. PubMed ID: 37586215
[TBL] [Abstract] [Full Text] [Related]
3. Long non-coding RNA MIR22HG inhibits the proliferation and migration, and promotes apoptosis by targeting microRNA-9-3p/ socs1 axis in small cell lung cancer cells.
Wang S; Wang Y; Li S; Nian S; Xu W; Liang F
Mol Biol Rep; 2023 Sep; 50(9):7445-7456. PubMed ID: 37479878
[TBL] [Abstract] [Full Text] [Related]
4. LncRNA KIAA0087 suppresses the progression of osteosarcoma by mediating the socs1/JAK2/STAT3 signaling pathway.
Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; He P; Zeng M
Exp Mol Med; 2023 Apr; 55(4):831-843. PubMed ID: 37009803
[TBL] [Abstract] [Full Text] [Related]
5. Deregulation of PRDM5 promotes cell proliferation by regulating JAK/STAT signaling pathway through socs1 in human lung adenocarcinoma.
Ren Y; Wang Y; Fang L; Ma M; Ge L; Su C; Xin L; He J; Yang J; Liu X
Cancer Med; 2023 Feb; 12(4):4568-4578. PubMed ID: 36127737
[TBL] [Abstract] [Full Text] [Related]
6. Ubenimex Combined with Pemetrexed Upregulates socs1 to Inhibit lung Adenocarcinoma Progression via the JAK2-STAT3 Signaling Pathway.
Chen Q; Wu B; Ge P; Zhang P; Chen X
Dis Markers; 2022; 2022():5614939. PubMed ID: 35789603
[TBL] [Abstract] [Full Text] [Related]
7. Rotation aiding technique for endobronchial ultrasound-guided transbronchial needle aspiration biopsy of intrathoracic lymph nodes: A complementary approach to the conventional jabbing method.
Ra SW; Lee T; Cha HJ; Park CR; Baek J; Chee Y; Kwon WJ
Thorac Cancer; 2022 Jun; 13(11):1712-1718. PubMed ID: 35501289
[TBL] [Abstract] [Full Text] [Related]
8. Exosomal miR-146a-5p and miR-155-5p promote CXCL12/CXCR7-induced metastasis of colorectal cancer by crosstalk with cancer-associated fibroblasts.
Wang D; Wang X; Song Y; Si M; Sun Y; Liu X; Cui S; Qu X; Yu X
Cell Death Dis; 2022 Apr; 13(4):380. PubMed ID: 35443745
[TBL] [Abstract] [Full Text] [Related]
9. Five circRNAs Serve as Potential Diagnostic and Prognostic Biomarkers in lung Adenocarcinoma.
Li Z; Ma G; Pan Y
Clin Lab; 2021 Aug; 67(8):. PubMed ID: 34383411
[TBL] [Abstract] [Full Text] [Related]
10. IL-10 suppresses IFN-γ-mediated signaling in lung adenocarcinoma.
Gao Y; Lu J; Zeng C; Yang J; Huang B; Zhang N; Li L; Fu X
Clin Exp Med; 2020 Aug; 20(3):449-459. PubMed ID: 32306136
[TBL] [Abstract] [Full Text] [Related]
11. Synergistic activation of p53 by actinomycin D and nutlin-3a is associated with the upregulation of crucial regulators and effectors of innate immunity.
Krześniak M; Zajkowicz A; Gdowicz-Kłosok A; Głowala-Kosińska M; Łasut-Szyszka B; Rusin M
Cell Signal; 2020 May; 69():109552. PubMed ID: 32032660
[TBL] [Abstract] [Full Text] [Related]
12. LncRNA
Li F; Hu Q; Pang Z; Xu X
Cancer Biother Radiopharm; 2020 Feb; 35(1):72-76. PubMed ID: 31910343
[No Abstract] [Full Text] [Related]
13. Tumor-intrinsic response to IFNγ shapes the tumor microenvironment and anti-PD-1 response in NSCLC.
Bullock BL; Kimball AK; Poczobutt JM; Neuwelt AJ; Li HY; Johnson AM; Kwak JW; Kleczko EK; Kaspar RE; Wagner EK; Hopp K; Schenk EL; Weiser-Evans MC; Clambey ET; Nemenoff RA
Life Sci Alliance; 2019 Jun; 2(3):. PubMed ID: 31133614
[TBL] [Abstract] [Full Text] [Related]
14.
Saigi M; Alburquerque-Bejar JJ; Mc Leer-Florin A; Pereira C; Pros E; Romero OA; Baixeras N; Esteve-Codina A; Nadal E; Brambilla E; Sanchez-Cespedes M
Clin Cancer Res; 2018 Sep; 24(18):4579-4587. PubMed ID: 29898990
[No Abstract] [Full Text] [Related]
15. Mimetics of suppressor of cytokine signaling 3: Novel potential therapeutics in triple breast cancer.
La Manna S; Lee E; Ouzounova M; Di Natale C; Novellino E; Merlino A; Korkaya H; Marasco D
Int J Cancer; 2018 Nov; 143(9):2177-2186. PubMed ID: 29752723
[TBL] [Abstract] [Full Text] [Related]
16. Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC.
Ge C; Li R; Song H; Geng T; Yang J; Tan Q; Song L; Wang Y; Xue Y; Li Z; Dong S; Zhang Z; Zhang N; Guo J; Hua L; Chen S; Song X
BMC Cancer; 2017 Dec; 17(1):884. PubMed ID: 29268708
[TBL] [Abstract] [Full Text] [Related]
17. Implication of downregulation and prospective pathway signaling of microRNA-375 in lung squamous cell carcinoma.
Chen WJ; Gan TQ; Qin H; Huang SN; Yang LH; Fang YY; Li ZY; Pan LJ; Chen G
Pathol Res Pract; 2017 Apr; 213(4):364-372. PubMed ID: 28214218
[TBL] [Abstract] [Full Text] [Related]
18. Signal Transducer and Activator of Transcription 1 (STAT1) Knock-down Induces Apoptosis in Malignant Pleural Mesothelioma.
Arzt L; Halbwedl I; Gogg-Kamerer M; Popper HH
Pathol Oncol Res; 2017 Jul; 23(3):595-605. PubMed ID: 27987139
[TBL] [Abstract] [Full Text] [Related]
19. MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating socs1, SOCS6, and PTEN.
Xue X; Liu Y; Wang Y; Meng M; Wang K; Zang X; Zhao S; Sun X; Cui L; Pan L; Liu S
Oncotarget; 2016 Dec; 7(51):84508-84519. PubMed ID: 27811366
[TBL] [Abstract] [Full Text] [Related]
20. MicroRNA-19a functions as an oncogenic microRNA in non-small cell lung cancer by targeting the suppressor of cytokine signaling 1 and mediating STAT3 activation.
Wang X; Chen Z
Int J Mol Med; 2015 Mar; 35(3):839-46. PubMed ID: 25604748
[TBL] [Abstract] [Full Text] [Related]
[Next]
